Advanced Therapies Xchange - Boston 2026

ABOUT THE EVENT

Date: Sunday, May 3, 2026 8am–6:15pm EDT
Event Location: Boston, Massachusetts

Advanced Therapies Xchange Boston 2026 invites senior-level scientists, R&D leaders, and executives from major pharmaceutical and biotech organisations to a one-day, high-impact forum dedicated to accelerating cell and gene therapy innovation.

This event focuses on the full advanced-therapies pipeline — including Next-Gen Vector Engineering & Delivery, Cell Therapy Development & Manufacturing, and Gene Therapy Development & Manufacturing. Through a combination of expert-led presentations, roundtable discussions, pre-booked 1:1 meetings, poster sessions, and networking breaks, attendees will explore cutting-edge solutions to the key scientific, manufacturing and regulatory challenges facing the industry today.

Speakers and contributors will include global leaders from across biopharma, offering insights on topics ranging from virus- and non-viral vector design, viral vector purity, lipid nanoparticle and exosome delivery, to scalable manufacturing approaches and quality-control strategies.

Date: Monday, May 4, 2026
Time: 08:00 AM – 06:15 PM
Location: Boston, MA, USA (Woburn) — venue details included in registration.
Registration: Complimentary for eligible senior-level delegates (pharma/biotech) with an active drug pipeline.

Don’t miss this opportunity to engage face-to-face with leading experts, shape the future of advanced therapies, and build meaningful collaborations across cell and gene therapy development.

MORE EVENTS
Taking an early proof of concept into preclinical and clinical development is a costly and complex process. But there are strategic ways to streamline the process and reduce risk and costs. In this webinar, you’ll hear directly from Nobel Laureate Sir Michael Houghton and experts from Applied Pharma, who bring decades of real-world success and deep scientific expertise.
Tuesday, February 24, 2026 12–1pm EST
 · 
Virtual
In this webinar, leading oncology experts Dr. Javier Cortés and Dr. Antonio Llombart-Cussac will explore how collaborative-initiated trials are transforming the clinical research landscape and creating new opportunities for scientific and clinical impact.
Monday, March 2, 2026 11am–12pm EST
 · 
Virtual
Artificial intelligence is rapidly reshaping the life sciences, from automating repetitive tasks to enabling advanced scientific and safety assessments across drugs, biologics, and devices. As adoption grows across regulators, pharmaceutical companies, technology developers, nonprofits, and collaborative consortia, the need for clear, risk-based frameworks for validation, governance and human oversight becomes increasingly critical.
Tuesday, March 17, 2026 1–2pm EDT
 · 
Virtual